Journals in Life sciences

11-20 of 429 results in All results

Advances in Redox Research

ISSN: 2667-1379

An official Journal of the Society for Redox Biology and Medicine and the Society for Free Radical Research-EuropeAn Affiliate Journal of the International Society for Free Radical Research (SFRRI) Advances in Redox Research is a peer-reviewed interdisciplinary journal which provides a platform for quality original research papers, short communications, invited reviews, and hypothesis papers focused on the broadest range of studies in oxidation-reduction (redox) processes in biology, biological chemistry, and health and disease - if biologically relevant.Novelty, methodologic accuracy, and soundness of conclusions are indispensable criteria for submission of papers. Confirmative or largely descriptive observations without valid data are not suitable for submission. Studies involving screening of food/plant materials will only be considered if the active component is both identified and quantified.There are no restrictions on length of articles. The journal aims to provide rapid and helpful peer-review to enable as many investigators as possible to publish their high-quality work.

Ageing Research Reviews

ISSN: 1568-1637
5 Year impact factor: 14.5
Impact factor: 13.1

As the average human life expectancy has increased, so too has the impact of ageing and age-related disease on our society. Ageing research is now the focus of thousands of laboratories that include leaders in the areas of genetics, molecular and cellular biology, biochemistry, and behaviour. Ageing Research Reviews (ARR) covers the trends in this field. It is designed to fill a large void, namely, a source for critical reviews and viewpoints on emerging findings on mechanisms of ageing and age-related disease. Rapid advances in understanding of mechanisms that control cellular proliferation, differentiation and survival are leading to new insight into the regulation of ageing. From telomerase to stem cells to energy and oxyradical metabolism, this is an exciting new era in the multidisciplinary field of ageing research. The cellular and molecular underpinnings of manipulations that extend lifespan, such as caloric restriction, are being identified and novel approaches for preventing age-related diseases are being developed. ARR publishes articles on focussed topics selected from the broad field of ageing research, with an emphasis on cellular and molecular mechanisms of the aging process and age-related diseases such as cancer, cardiovascular disease, diabetes and neurodegenerative disorders. Applications of basic ageing research to lifespan extension and disease prevention are also covered in this journal.

Alcohol

ISSN: 0741-8329
5 Year impact factor: 2.3
Impact factor: 2.3

Alcohol is an international, peer-reviewed journal that is devoted to publishing multi-disciplinary biomedical research on all aspects of the actions or effects of alcohol on the nervous system or on other organ systems. Emphasis is given to studies into the causes and consequences of alcohol abuse and alcoholism, and biomedical aspects of diagnosis, etiology, treatment or prevention of alcohol-related health effects. Intended for both research scientists and practicing clinicians, the journal publishes original research on the neurobiological, neurobehavioral, and pathophysiological processes associated with alcohol drinking, alcohol abuse, alcohol-seeking behavior, tolerance, dependence, withdrawal, protracted abstinence, and relapse. In addition, the journal reports studies on the effects alcohol on brain mechanisms of neuroplasticity over the life span, biological factors associated with adolescent alcohol abuse, pharmacotherapeutic strategies in the treatment of alcoholism, biological and biochemical markers of alcohol abuse and alcoholism, pathological effects of uncontrolled drinking, biomedical and molecular factors in the effects on liver, immune system, and other organ systems, and biomedical aspects of fetal alcohol spectrum disorder including mechanisms of damage, diagnosis and early detection, treatment, and prevention. Articles are published from all levels of biomedical inquiry, including the following: molecular and cellular studies of alcohol's actions in vitro and in vivo; animal model studies of genetic, pharmacological, behavioral, developmental or pathophysiological aspects of alcohol; human studies of genetic, behavioral, cognitive, neuroimaging, or pathological aspects of alcohol drinking; clinical studies of diagnosis (including dual diagnosis), treatment, prevention, and epidemiology. The journal will publish 9 issues per year; the accepted abbreviation for Alcohol for bibliographic citation is Alcohol. Alcohol subscribes to the tenets of The Farmington Consensus. Submission of a paper to the journal will be taken as evidence that the authors have complied with the tenets set forth in the Consensus. All submitted material will be subject to peer review. Alcohol considers three types of manuscripts for publication: - Original research articles are full-length reports of the authors' original research addressing topics consistent with the Aims and Scope of the journal. Submissions outside the scope of the journal, or incomplete or fragmentary submissions, will not be considered. - Rapid communications are original, high-quality manuscripts that describe new data of high impact and major importance to the field. These contributions are typically short (e.g., 4 journal pages), and will be peer-reviewed by at least one expert in the field of the research and an Editor, and will be either accepted with minimal or no revisions or rejected. Publication of accepted rapid communications will be expedited. - Invited review articles will be considered for publication, upon invitation from the Editor-in-Chief, as full-length papers or mini-reviews. These contributions will be peer-reviewed. Contact the Editor-in-Chief concerning the suitability of a topic for an invited review.

Alexandria Journal of Medicine

ISSN: 2090-5068

As of 1 January 2019 the journal has been transferred to the new Publisher, Taylor and Francis.The Alexandria Journal of Medicine is concerned with providing a venue for publication of research, with a particular focus on diseases of high prevalence in MENA (Middle East and North Africa) and its comparison to their profile worldwide. Manuscripts from the international scientific community are also welcome to cater to the interests of our broad readership, both regional and worldwide and to increase the opportunities for fruitful interregional scientific collaboration. The journal publishes original research articles, review articles, short communications and clinical trials in an open access format. Furthermore, time to first decision has been set to be within 6 weeks to facilitate rapid dissemination of high quality accepted articles.

Algal Research

ISSN: 2211-9264
5 Year impact factor: 5.5
Impact factor: 5.1

Biomass, Biofuels and Bioproducts Algal Research is an international phycology journal covering all areas of emerging technologies in algae biology, biomass production, cultivation, harvesting, extraction, bioproducts, biorefinery, engineering, and econometrics. Algae is defined to include cyanobacteria, microalgae, macroalgae, and protists and symbionts of interest in biotechnology. The journal publishes original research and reviews for the following scope: algal biology, including but not exclusive to: phylogeny, biodiversity, molecular traits, metabolic regulation, and genetic engineering, algal cultivation, e.g. phototrophic systems, heterotrophic systems, and mixotrophic systems, algal harvesting and extraction systems, biotechnology to convert algal biomass and components into biofuels and bioproducts, e.g., nutraceuticals, pharmaceuticals, animal feed, plastics, etc. algal products and their economic assessment Papers in the latter topics should include characterization and analysis in support of such processes and technologies, for example:approaches to biorefinery and biomass characterization, sustainability assessments and analyses, such as techno-economic, life cycle, and resource assessments of systems and processes using algae as a main source of biomass. The journal will not consider manuscripts where the core concept is the experimental design (RSM, CCD or other) in the opitmization of a process, or the biological activity of algae extracts without full characterization and identification of the compounds responsible for the bioactivity. Review articles, book reviews and commentaries should only be submitted after consultation with the Editors. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Review articles, book reviews and commentaries should only be submitted after consultation with the Editors.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Anaerobe

ISSN: 1075-9964
5 Year impact factor: 2.9
Impact factor: 2.3

The Official Journal of the Anaerobe Society of the Americas and the Japanese Association for Anaerobic Infection Research Anaerobe is essential reading for those who wish to remain at the forefront of discoveries relating to life processes of strictly anaerobes. The journal is multi-disciplinary, and provides a unique forum for those investigating strictly anaerobic organisms that cause infections in humans and animals, as well as anaerobes that play roles in microbiomes or environmental processes. Anaerobe will consider manuscripts on anaerobic bacteria, archaea, fungi, protists as well as bacteriophages of anaerobes. Relevant topics fall into the broad categories of: Anaerobes in human and animal diseases Anaerobes in the microbiome Anaerobes in the environment Anaerobes in industrial processes (including biofuels and waste management) Microbial ecology of anaerobes Clinical microbiology involving anaerobes Pathogenesis of anaerobic organisms (including their toxins) Molecular biology and genetics of anaerobes Taxonomy of anaerobes Physiology of anaerobes Papers describing innovative methodologies, technologies and applications to investigate anaerobic microorganisms are also of interest. Manuscripts describing novel species of obligate anaerobes will be reviewed, if the description of the new species also includes information showing novel phenotypic characteristics, pathogenicity and/or unique metabolic activity within the microbiome from which it was isolated. Manuscripts describing novel anaerobic species that are only different from other related members of a genus based on genotype will not be reviewed. Manuscript types accepted (see Guide for Authors for more information): Original research articlesOriginal research reports on one or more of the above listed categories. Up to 4000 words, not including a structured abstract, figures, tables and references. Short CommunicationsPresentation of brief observations that do not warrant a full-length publication. Up to 1500 words not including abstract, figures, tables and references. Short communications should report complete datasets and not preliminary findings. Reviews and minireviewsReviews are typically 7,000 words in length including relevant tables and/or figures. Mini-reviews are typically restricted to 2,500 words in length. *New from March 1st 2023: Anaerobe no longer accepts unsolicited reviews and standalone mini-reviews. Proposals for reviews and mini-reviews within the topics mentioned above are welcome for consideration by the journal. Please provide a proposed title and detailed outline of the topic to be covered to an editor-in-chief by email. Case reportsPresentation of a short report on a significant clinical observation, preceded by a minireview (up to 2500 words) of the literature describing the background of similar cases/infections, what is known about the associated microbe, and other clinically relevant information. *New from March 2023: Case Reports will only be considered in this new format. Commentaries Occasionally, Anaerobe will consider publication of commentaries on important new work in the field. Such commentaries will be invited by the editors-in-chief. Suggestions for commentaries may be emailed to an Editor-in-Chief. Unsolicited commentaries will not be considered. Please note: 1. Anaerobe does not accept manuscripts on descriptive, sequence-based surveys of microbiomes, even if the environments of the sampled ecosystems select for anaerobic species. However, when studies such as these are accompanied by direct, mechanistic assays of strictly anaerobic components, they will be considered for publication. 2. Anaerobe will not consider manuscripts that deal only with descriptive accounts of the beneficial effects of potentially novel probiotic strains, unless such strains belong to strictly anaerobic species that have previously not been associated with probiotic features. Anaerobe will continue to consider manuscripts for publication that address determinations of the specific mechanism(s) of action of anaerobic probiotic strains.

Analytical Biochemistry

ISSN: 0003-2697
5 Year impact factor: 3.2
Impact factor: 2.9

Methods in the Biological Sciences The journal's title Analytical Biochemistry: Methods in the Biological Sciences declares its broad scope: methods for the basic biological sciences that include biochemistry, molecular genetics, cell biology, proteomics, immunology, bioinformatics and wherever the frontiers of research take the field. The emphasis is on methods from the strictly analytical to the more preparative that would include novel approaches to protein purification as well as improvements in cell and organ culture. The actual techniques are equally inclusive ranging from aptamers to zymology. The journal has been particularly active in: Analytical techniques for biological molecules Aptamer selection and utilization Biosensors Chromatography Cloning, sequencing and mutagenesis Electrochemical methods Electrophoresis Enzyme characterization methods Immunological approaches Magnetic resonance spectroscopy (in vivo) Mass spectrometry of proteins and nucleic acids Metabolomics Nano level techniques Optical spectroscopy in all its forms The journal is reluctant to include most drug and strictly clinical studies as there are more suitable publication platforms for these types of papers. Apart from full-length original research papers, the journal also welcomes Review papers, and Notes and Tips - featuring methods that can be summarized in a shorter format article, including helpful "kitchen tricks".

Animal Gene

ISSN: 2352-4065

This journal will be closed after December 31, 2023. Authors are invited to submit their manuscripts to Gene Reports or Gene. Animal Gene is a companion title to Gene and a member of the Gene Family. Animal Gene publishes papers that focus on the regulation, expression, function and evolution of genes in animals. Animal Gene strives to be a diverse journal and topics in multiple fields will be considered for publication so long as their main focus is on animals, such as but not limited to cattle, pig, sheep, goat, chicken, fish, mollusks, crustaceans, insects, or microorganisms. Potential topics include: Genetic discovery and characterization. Genetic markers to guide traditional breeding. Genetic effects of transposable elements. Evolutionary genetics, molecular evolution, population genetics, and phylogenetics. Profiling of gene expression and genetic variation. Biotechnology and livestock improvement. Genetic improvement of biological control microorganisms. Genetic control of secondary metabolic pathways and metabolic enzymes of animal pathogens. Animal Gene encourages submission of novel manuscripts that present a reasonable level of analysis, functional relevance and/or mechanistic insight. Animal Gene also welcomes papers that have predominantly a descriptive component but improve the essential basis of knowledge for subsequent functional studies, or which provide important confirmation of recently published discoveries provided that the information is new. Please note: Animal Gene was previously called Agri Gene and its title was changed on Jan 1st 2020. The journal is a member of the GENE Family. Authors are also welcome to submit to the other journals that make up the Gene Family: Gene, Gene: X, Gene Reports, Meta Gene .

Animals and Zoonoses

ISSN: 2950-2489

Animals and Zoonoses is an international peer-reviewed, open access, professional academic journal: all accepted articles are immediately and permanently available on ScienceDirect, and are free to read, download and share. It focuses on emerging zoonotic diseases and publishes the latest research results, case reports, short communication and reviews in veterinary medicine, animal science and biomedicine. The primary aim of the journal is to promote academic exchange through prompt publication and dissemination. The journal covers the following areas: Zoonotic diseases section focuses on tracing the original source of epidemic, etiology, epidemiology, diagnosis and detection, prevention and vaccine development of epidemic diseases. Veterinary medicine section focuses on veterinary physiology, pathology, anatomy, veterinary epidemiology and public health, veterinary microbiology and immunology, veterinary virology and parasitology, etc. Animal science section focuses on animal genetic breeding and bioinformatics, animal nutrition and metabolic diseases, animal food safety, and laboratory zoology, etc. Biomedical science section focuses on molecular biology, cell biology and biochemistry, etc. We welcome manuscripts on original research results and reviews of basic and cutting-edge research. We also encourage submissions of relevant research that are not listed above. For detailed information on the submission categories, please refer to the Guide for Authors before submission.

Antiviral Research

ISSN: 0166-3542
5 Year impact factor: 5.8
Impact factor: 7.6

A journal for research on the prevention and treatment of viral diseasesAn Official Publication of the International Society for Antiviral Research Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses: antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action. new or improved vaccines against viral infections of humans; assessments of drug and vaccine safety; evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures; identification and validation of new drug targets; laboratory animal models of viral diseases; pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses. We encourage the submission of manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases of humans and vertebrate animals. We also publish manuscripts on the protective activity of vaccines for humans, and we will consider reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis. Note: Antiviral Research may choose not to publish certain COVID-19 papers. The COVID-19 pandemic has focused attention on the possibility that patients infected with SARS-CoV-2 might benefit from treatment with certain licensed drugs approved for conditions other than viral infection. Reports that various medications inhibit the replication of the virus in vitro have been widely publicized in news articles and on medical websites, giving the impression that compounds still in the earliest stage of evaluation may be used to prevent or treat COVID-19. Such misunderstanding may result in the inappropriate use of a drug by physicians and to self-treatment by people who obtain it from other sources, with a risk of toxicity. This may be a particular problem when a medication is available without prescription as a veterinary product. Hoarding or inappropriate use of a drug intended to treat another disease may also make it unavailable to patients with that disease. The editors of Antiviral Research may therefore choose not to publish certain COVID-19 manuscripts, when in our judgment publication is likely to result in harm, without clear evidence of benefit. The scope of AVR also includes the prevention and treatment of viral diseases of vertebrate animals. We do not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species. We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We also discourage submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]." Antiviral Research is an official publication of the International Society for Antiviral Research (http://www.isar-icar.com). Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center